Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa.

Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa.

Bibliographic Details
Main Authors:	Karen Shean, Elizabeth Streicher, Elize Pieterson, Greg Symons, Richard van Zyl Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul Wilcox, Tommie C. Victor, Paul van Helden, Martin P. Grobusch, Robin Warren, Motasim Badri, Keertan Dheda
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3669431

Similar Items

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.
by: Karen Shean, et al.
Published: (2013-01-01)

High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis.
by: Elize Pietersen, et al.
Published: (2015-01-01)

Disease severity and status in Stevens–Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs
by: Rannakoe J. Lehloenya, et al.
Published: (2022-09-01)

Early treatment outcomes of patients with extensively drug resistant tuberculosis in South Africa
by: S. Janssen, et al.
Published: (2014-04-01)

Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients
by: Tafadzwa Chimbetete, et al.
Published: (2023-05-01)

Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa
by: Elize Pietersen, et al.
Published: (2023-01-01)

Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
by: Elize Pietersen, et al.
Published: (2023-01-01)

Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting.
by: Grant Theron, et al.
Published: (2012-01-01)

Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review.
by: Richard N van Zyl-Smit, et al.
Published: (2009-12-01)

HIV-associated photodermatitis in African populations
by: Thuraya Isaacs, et al.
Published: (2023-05-01)

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Keertan Dheda, et al.
Published: (2014-10-01)

Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting.
by: Keertan Dheda, et al.
Published: (2009-01-01)

Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?
by: Jonathan G Peter, et al.
Published: (2013-01-01)

Selection and application of ssDNA aptamers to detect active TB from sputum samples.
by: Lia S Rotherham, et al.
Published: (2012-01-01)

Factors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysis.
by: Lauren Knight, et al.
Published: (2014-01-01)

In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.
by: Lucy C K Bell, et al.
Published: (2016-03-01)

Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden.
by: Richard N van Zyl-Smit, et al.
Published: (2011-01-01)

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis
by: Rook Graham, et al.
Published: (2010-02-01)

ICU-associated Acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting.
by: Ntobeko B A Ntusi, et al.
Published: (2012-01-01)

Development of a simple reliable radiographic scoring system to aid the diagnosis of pulmonary tuberculosis.
by: Lancelot M Pinto, et al.
Published: (2013-01-01)

The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
by: Jonathan G Peter, et al.
Published: (2012-01-01)

The non-clonality of drug resistance in Beijing-genotype isolates of <it>Mycobacterium tuberculosis </it>from the Western Cape of South Africa
by: Van Helden Paul D, et al.
Published: (2010-11-01)

Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa
by: Marisa Klopper, et al.
Published: (2013-03-01)

Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women.
by: Lauren Knight, et al.
Published: (2015-01-01)

Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa
by: Alistair D. Calver, et al.
Published: (2010-02-01)

Patterns of adverse drug reactions (ADRs) in Saudi Arabia
by: Nora Bin Yousef, et al.
Published: (2022-01-01)

The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report
by: Malika Davids, et al.
Published: (2021-06-01)

Seks & Drugs & Boeremusiek: Die memoires van 'n volksverraaier
by: Stefan van Zyl
Published: (2016-11-01)

Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.
by: Keertan Dheda, et al.
Published: (2010-03-01)

Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative study
by: Musonda Sharon Machona, FCDerm(SA), et al.
Published: (2024-08-01)

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant <it>Acinetobacter baumannii </it>infections
by: Cohen Karen, et al.
Published: (2009-03-01)

Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden
by: Thuli Mthiyane, et al.
Published: (2015-07-01)

Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
by: Borna Müller, et al.
Published: (2013-01-01)

Feasibility and diagnostic utility of antigen-specific interferon-gamma responses for rapid immunodiagnosis of tuberculosis using induced sputum.
by: Tamaryn J Cashmore, et al.
Published: (2010-04-01)

Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action
by: Ruth McNerney, et al.
Published: (2017-03-01)

Genetic diversity of Mycobacterium tuberculosis complex strains isolated from livestock workers and cattle in Nigeria.
by: Hezekiah K Adesokan, et al.
Published: (2019-01-01)

Relationship between chest radiographic characteristics, sputum bacterial load, and treatment outcomes in patients with extensively drug-resistant tuberculosis
by: J.B. te Riele, et al.
Published: (2019-02-01)

Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent.
by: Madeleine Hanekom, et al.
Published: (2013-01-01)

Antimalarial drug quality in Gabon
by: B.J. Visser, et al.
Published: (2014-04-01)

The role of concurrent sexual relationships in the spread of sexually transmitted infections in young South Africans
by: Chris Kenyon, et al.
Published: (2009-03-01)